Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Functions of Tfh Cells in Common Variable Immunodeficiency.

Le Saos-Patrinos C, Loizon S, Blanco P, Viallard JF, Duluc D.

Front Immunol. 2020 Jan 30;11:6. doi: 10.3389/fimmu.2020.00006. eCollection 2020. Review.

2.

Beyond the tumour microenvironment.

Laplane L, Duluc D, Bikfalvi A, Larmonier N, Pradeu T.

Int J Cancer. 2019 Nov 15;145(10):2611-2618. doi: 10.1002/ijc.32343. Epub 2019 Apr 29. Review.

3.

The Multiple Layers of the Tumor Environment.

Laplane L, Duluc D, Larmonier N, Pradeu T, Bikfalvi A.

Trends Cancer. 2018 Dec;4(12):802-809. doi: 10.1016/j.trecan.2018.10.002. Epub 2018 Oct 24. Review.

PMID:
30470302
4.

Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications.

Turpin D, Furudoi A, Parrens M, Blanco P, Viallard JF, Duluc D.

Clin Immunol. 2018 Dec;197:130-138. doi: 10.1016/j.clim.2018.09.006. Epub 2018 Sep 13.

PMID:
30219667
5.

T Follicular Helper Cells in Autoimmune Disorders.

Gensous N, Charrier M, Duluc D, Contin-Bordes C, Truchetet ME, Lazaro E, Duffau P, Blanco P, Richez C.

Front Immunol. 2018 Jul 17;9:1637. doi: 10.3389/fimmu.2018.01637. eCollection 2018. Review.

6.

The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage Infection.

Howard J, Loizon S, Tyler CJ, Duluc D, Moser B, Mechain M, Duvignaud A, Malvy D, Troye-Blomberg M, Moreau JF, Eberl M, Mercereau-Puijalon O, Déchanet-Merville J, Behr C, Mamani-Matsuda M.

J Infect Dis. 2017 May 15;215(10):1569-1579. doi: 10.1093/infdis/jix149.

PMID:
28368498
7.

Dendritic cell targeting vaccine for HPV-associated cancer.

Yin W, Duluc D, Joo H, Oh S.

Cancer Cell Microenviron. 2016;3(4). pii: e1482. Epub 2017 Jan 15.

8.

Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity.

Yin W, Duluc D, Joo H, Xue Y, Gu C, Wang Z, Wang L, Ouedraogo R, Oxford L, Clark A, Parikh F, Kim-Schulze S, Thompson-Snipes L, Lee SY, Beauregard C, Woo JH, Zurawski S, Sikora AG, Zurawski G, Oh S.

Cancer Immunol Res. 2016 Oct;4(10):823-834. Epub 2016 Aug 2.

9.

Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.

Yin W, Gorvel L, Zurawski S, Li D, Ni L, Duluc D, Upchurch K, Kim J, Gu C, Ouedraogo R, Wang Z, Xue Y, Joo H, Gorvel JP, Zurawski G, Oh S.

EBioMedicine. 2016 Jan 28;5:46-58. doi: 10.1016/j.ebiom.2016.01.029. eCollection 2016 Mar.

10.

Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments.

Duluc D, Banchereau R, Gannevat J, Thompson-Snipes L, Blanck JP, Zurawski S, Zurawski G, Hong S, Rossello-Urgell J, Pascual V, Baldwin N, Stecher J, Carley M, Boreham M, Oh S.

Genome Med. 2014 Nov 25;6(11):98. doi: 10.1186/s13073-014-0098-y. eCollection 2014.

11.

Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.

Parikh F, Duluc D, Imai N, Clark A, Misiukiewicz K, Bonomi M, Gupta V, Patsias A, Parides M, Demicco EG, Zhang DY, Kim-Schulze S, Kao J, Gnjatic S, Oh S, Posner MR, Sikora AG.

Cancer Res. 2014 Dec 15;74(24):7205-16. doi: 10.1158/0008-5472.CAN-14-1913. Epub 2014 Oct 15.

12.

C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses.

Joo H, Li D, Dullaers M, Kim TW, Duluc D, Upchurch K, Xue Y, Zurawski S, Le Grand R, Liu YJ, Kuroda M, Zurawski G, Oh S.

Immunity. 2014 Oct 16;41(4):592-604. doi: 10.1016/j.immuni.2014.09.009. Epub 2014 Oct 9.

13.

IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells.

Miot C, Beaumont E, Duluc D, Le Guillou-Guillemette H, Preisser L, Garo E, Blanchard S, Hubert Fouchard I, Créminon C, Lamourette P, Fremaux I, Calès P, Lunel-Fabiani F, Boursier J, Braum O, Fickenscher H, Roingeard P, Delneste Y, Jeannin P.

Gut. 2015 Sep;64(9):1466-75. doi: 10.1136/gutjnl-2013-306604. Epub 2014 Sep 2.

PMID:
25183206
14.

Induction and activation of human Th17 by targeting antigens to dendritic cells via dectin-1.

Duluc D, Joo H, Ni L, Yin W, Upchurch K, Li D, Xue Y, Klucar P, Zurawski S, Zurawski G, Oh S.

J Immunol. 2014 Jun 15;192(12):5776-88. doi: 10.4049/jimmunol.1301661. Epub 2014 May 16.

15.

Dendritic cells and vaccine design for sexually-transmitted diseases.

Duluc D, Gannevat J, Joo H, Ni L, Upchurch K, Boreham M, Carley M, Stecher J, Zurawski G, Oh S.

Microb Pathog. 2013 May;58:35-44. doi: 10.1016/j.micpath.2012.11.010. Epub 2012 Nov 29. Review.

16.

Functional diversity of human vaginal APC subsets in directing T-cell responses.

Duluc D, Gannevat J, Anguiano E, Zurawski S, Carley M, Boreham M, Stecher J, Dullaers M, Banchereau J, Oh S.

Mucosal Immunol. 2013 May;6(3):626-38. doi: 10.1038/mi.2012.104. Epub 2012 Nov 7.

17.

Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.

Li D, Romain G, Flamar AL, Duluc D, Dullaers M, Li XH, Zurawski S, Bosquet N, Palucka AK, Le Grand R, O'Garra A, Zurawski G, Banchereau J, Oh S.

J Exp Med. 2012 Jan 16;209(1):109-21. doi: 10.1084/jem.20110399. Epub 2012 Jan 2.

18.

IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ.

Jeannin P, Duluc D, Delneste Y.

Immunotherapy. 2011 Apr;3(4 Suppl):23-6. doi: 10.2217/imt.11.30. Review.

PMID:
21524164
19.

Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses.

Ni L, Gayet I, Zurawski S, Duluc D, Flamar AL, Li XH, O'Bar A, Clayton S, Palucka AK, Zurawski G, Banchereau J, Oh S.

J Immunol. 2010 Sep 15;185(6):3504-13. doi: 10.4049/jimmunol.1000999. Epub 2010 Aug 20.

20.

The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling.

Crabé S, Guay-Giroux A, Tormo AJ, Duluc D, Lissilaa R, Guilhot F, Mavoungou-Bigouagou U, Lefouili F, Cognet I, Ferlin W, Elson G, Jeannin P, Gauchat JF.

J Immunol. 2009 Dec 15;183(12):7692-702. doi: 10.4049/jimmunol.0901464.

21.

PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta.

Duluc D, Tan F, Scotet M, Blanchard S, Frémaux I, Garo E, Horvat B, Eid P, Delneste Y, Jeannin P.

Eur J Immunol. 2009 Oct;39(10):2877-84. doi: 10.1002/eji.200838610.

22.

Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages.

Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, Gamelin E, Ponsoda S, Delneste Y, Hebbar M, Jeannin P.

Int J Cancer. 2009 Jul 15;125(2):367-73. doi: 10.1002/ijc.24401.

23.

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.

Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N, Descamps P, Gamelin E, Gascan H, Hebbar M, Jeannin P.

Blood. 2007 Dec 15;110(13):4319-30. Epub 2007 Sep 11.

PMID:
17848619
24.
25.

Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.

Caron G, Duluc D, Frémaux I, Jeannin P, David C, Gascan H, Delneste Y.

J Immunol. 2005 Aug 1;175(3):1551-7.

Supplemental Content

Support Center